26 July 2018 - In May, the President gave his first major speech on lowering drug prices, making good on his campaign promise to go after drug makers to get lower prices for consumers. 

Following the speech, the White House released the Administration’s blueprint for lowering drug prices. Two months later, some of the details of the plan are now starting to come into focus and we are seeing results.

For example, the drug companies Pfizer, Novartis, and Merck all announced that they were reversing decisions to raise drug prices this year and even offering discounts on some drugs. This is great news for patients especially when millions of Americans are skipping doses or not filling expensive prescriptions to try to save money.

Read The Hill article